Enhanced expression of anti-apoptotic Bcl-2 proteins is frequently observed in malignancies of diverse origin, e.g. Bfl-1 in diffuse large-cell lymphoma [49] and Bcl-xL in lung adenocarcinoma [50]. This evidence concerns the gene BCL2 and lung adenocarcinoma.